+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-invasive Prenatal Testing Market - Global Forecast 2026-2032- Product Image
Non-invasive Prenatal Testing Market - Global Forecast 2026-2032- Product Image
New

Non-invasive Prenatal Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968595
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Non-invasive prenatal testing (NIPT) is reshaping prenatal diagnostics and introducing significant operational and strategic opportunities for healthcare leaders and laboratory executives. With adoption rates rising globally, NIPT enables organizations to meet emerging clinical demands, enhance service quality, and maintain a strong market stance amid shifting regulations and payer expectations.

Market Snapshot: Non-invasive Prenatal Testing Market

The Non-invasive Prenatal Testing Market advanced from USD 6.93 billion in 2025 to USD 7.36 billion in 2026, underpinned by a compounded annual growth rate (CAGR) of 8.10% and forecast to reach USD 11.95 billion by 2032. Growth is propelled by the adoption of advanced genetic screening tools, evolving reimbursement frameworks, and regulatory policies. The landscape further benefits from supply chain innovation and inter-industry collaborations, both of which facilitate broader access and strengthen operational delivery. As clinical requirements evolve, organizations increasingly prioritize the integration of new genomic applications and greater workflow efficiency to sustain patient care excellence.

Scope & Segmentation of the Report

This report provides in-depth strategic analysis designed to inform executive decision-making, focusing on the following key segments and dynamics shaping the Non-invasive Prenatal Testing Market:

  • Test Modalities: Widespread trisomy screening, comprehensive microdeletion panels, sex chromosome aneuploidy detection, and coverage of whole-genome applications.
  • Technological Platforms: Microarray technology, next-generation sequencing for analysis of cell-free DNA, PCR-based rapid assessment, and proprietary amplification approaches.
  • Gestational Timing: Early and late-term sampling and its impact on result validity and genetic counseling pathways.
  • Delivery Channels: Home-based sample collection, high-throughput laboratory workflow models, and new pilot initiatives around point-of-care service.
  • End-User Behaviors: Decision-making processes of diagnostic laboratories, coordinated hospital networks, and specialized clinics integrating counseling with testing.
  • Geographic Regions: Analysis of market activity and adoption drivers in the Americas, Europe, Middle East & Africa, and Asia-Pacific regions, with a focus on regulatory, cultural, and distributional influences.

Key Takeaways for Decision-Makers

  • Expanding sequencing options and molecular diagnostic techniques support the detection of a broader range of prenatal conditions and enable clinicians to consider new intervention strategies.
  • Payer and regulatory changes are prompting organizations to refine product development, documentation, and market entry strategies, with growing attention to demonstrating clinical utility.
  • Strategic supply chain management, including emphasis on local sourcing and procurement optimization, is critical for maintaining reliable service delivery as operational pressures mount.
  • Adoption of integrated analytics, consistent genetic counseling, and frictionless interoperability with health record systems drives provider preference and broader clinical acceptance.
  • Variations in regional distribution, clinical infrastructure, and access guidelines require tailored education, engagement, and commercialization strategies to capture potential across diverse geographies.
  • Leveraging real-world evidence and stakeholder alignment enhances organizational agility and creates opportunities as regulations and market expectations evolve.

Tariff Impact: Operational and Strategic Responses

The enactment of U.S. tariffs in 2025 introduced cost pressures throughout the NIPT value chain, affecting laboratories, diagnostic vendors, and logistics providers. In response, industry participants shifted towards regional suppliers, renegotiated procurement agreements, and streamlined distribution to improve efficiency. Building domestic distribution capacity and updating inventory processes supported stable service provision while enabling proactive engagement with payers concerning reimbursement structures aligned to new cost realities.

Methodology & Data Sources

Findings in this report are derived from structured analysis of published clinical data, official regulatory communications, and validated technical documentation, further substantiated by direct interviews with laboratory directors, genetic counseling professionals, and supply chain experts. Scenario modeling and cross-segmentation validate significant trends, and data privacy standards are rigorously upheld throughout the research process.

Why This Report Matters

  • Enables benchmarking of technology adoption, commercialization pathways, and policy influences on the Non-invasive Prenatal Testing Market for senior executives.
  • Provides actionable recommendations to navigate risk, strengthen market entry strategies, and harmonize health system deliverables with shifting payer and clinical requirements.
  • Offers a research-backed framework for decisions in innovation, stakeholder training, and payer engagement to underpin robust, sustainable market growth.

Conclusion

NIPT is at a crucial juncture where clinical progress, supply assurance, and regulatory realignment intersect. Leaders who emphasize robust evidence, adaptive procurement, and collaborative clinician involvement will be positioned to realize ongoing improvements in prenatal diagnostics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Non-invasive Prenatal Testing Market, by Test Type
8.1. Aneuploidy Screening
8.1.1. Trisomy 13 (Patau Syndrome)
8.1.2. Trisomy 18 (Edwards Syndrome)
8.1.3. Trisomy 21 (Down Syndrome)
8.2. Microdeletion Syndromes
8.2.1. 1p36 Deletion
8.2.2. 22q11.2 Deletion (DiGeorge Syndrome)
8.2.3. Cri-du-chat Syndrome
8.3. Sex Chromosome Aneuploidies (SCA)
8.3.1. Klinefelter Syndrome (XXY)
8.3.2. Triple X Syndrome (XXX)
8.3.3. Turner Syndrome (Monosomy X)
8.3.4. XYY Syndrome
8.4. Whole-Genome Screening
9. Non-invasive Prenatal Testing Market, by By Technology
9.1. Microarray-Based Analysis
9.2. Next-Generation Sequencing (NGS)
9.3. Polymerase Chain Reaction (PCR)
9.4. Rolling Circle Amplification (RCA)
10. Non-invasive Prenatal Testing Market, by Gestation Period
10.1. 10-17 Week
10.2. 18-23 Week
10.3. Above 23 Week
11. Non-invasive Prenatal Testing Market, by Mode of Delivery
11.1. At-Home Sample Collection
11.2. Laboratory-Based Testing Services
11.3. Point-of-Care Testing
12. Non-invasive Prenatal Testing Market, by End-User
12.1. Diagnostic Laboratories
12.2. Hospitals
12.3. Specialty Clinics
13. Non-invasive Prenatal Testing Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Non-invasive Prenatal Testing Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Non-invasive Prenatal Testing Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Non-invasive Prenatal Testing Market
17. China Non-invasive Prenatal Testing Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Agilent Technologies, Inc.
18.6. BGI Group
18.7. BillionToOne, Inc.
18.8. Biora Therapeutics, Inc.
18.9. BioReference Laboratories, Inc.
18.10. Centogene N.V.
18.11. Eurofins Scientific SE
18.12. F.Hoffmann-La Roche Ltd.
18.13. GE HealthCare Technologies Inc.
18.14. Igenomix S.L.U by Vitrolife Group
18.15. Illumina, Inc.
18.16. Labcorp Holdings Inc.
18.17. Laboratory Corporation of America Holdings
18.18. Lilac Insights Pvt. Ltd.
18.19. MedGenome Labs Ltd.
18.20. Myriad Genetics, Inc.
18.21. Natera, Inc.
18.22. Quest Diagnostics Incorporated
18.23. Ravgen Inc.
18.24. Sonic Healthcare USA
18.25. Thermo Fisher Scientific Inc.
18.26. Yourgene Health by Novacyt UK Holdings Limited
List of Figures
FIGURE 1. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY 13 (PATAU SYNDROME), BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY 13 (PATAU SYNDROME), BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY 13 (PATAU SYNDROME), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY 18 (EDWARDS SYNDROME), BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY 18 (EDWARDS SYNDROME), BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY 18 (EDWARDS SYNDROME), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY 21 (DOWN SYNDROME), BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY 21 (DOWN SYNDROME), BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY 21 (DOWN SYNDROME), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 1P36 DELETION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 1P36 DELETION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 1P36 DELETION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 22Q11.2 DELETION (DIGEORGE SYNDROME), BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 22Q11.2 DELETION (DIGEORGE SYNDROME), BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 22Q11.2 DELETION (DIGEORGE SYNDROME), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CRI-DU-CHAT SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CRI-DU-CHAT SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CRI-DU-CHAT SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY KLINEFELTER SYNDROME (XXY), BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY KLINEFELTER SYNDROME (XXY), BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY KLINEFELTER SYNDROME (XXY), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRIPLE X SYNDROME (XXX), BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRIPLE X SYNDROME (XXX), BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRIPLE X SYNDROME (XXX), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TURNER SYNDROME (MONOSOMY X), BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TURNER SYNDROME (MONOSOMY X), BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TURNER SYNDROME (MONOSOMY X), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY XYY SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY XYY SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY XYY SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY WHOLE-GENOME SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY WHOLE-GENOME SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY WHOLE-GENOME SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAY-BASED ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAY-BASED ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAY-BASED ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING (NGS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION (RCA), BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION (RCA), BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION (RCA), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 10-17 WEEK, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 10-17 WEEK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 10-17 WEEK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 18-23 WEEK, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 18-23 WEEK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY 18-23 WEEK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ABOVE 23 WEEK, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ABOVE 23 WEEK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ABOVE 23 WEEK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY AT-HOME SAMPLE COLLECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY AT-HOME SAMPLE COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY AT-HOME SAMPLE COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY LABORATORY-BASED TESTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY LABORATORY-BASED TESTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY LABORATORY-BASED TESTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 97. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 128. EUROPE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. EUROPE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 130. EUROPE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 131. EUROPE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 132. EUROPE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 133. EUROPE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 135. EUROPE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 136. EUROPE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 146. AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 148. AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 149. AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 150. AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 151. AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 153. AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 154. AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. ASEAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. ASEAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 167. ASEAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 168. ASEAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 169. ASEAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 170. ASEAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 171. ASEAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 172. ASEAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 173. ASEAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 174. GCC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GCC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 176. GCC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 177. GCC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 178. GCC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 179. GCC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 180. GCC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 181. GCC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 182. GCC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 192. BRICS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. BRICS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 194. BRICS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 195. BRICS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 196. BRICS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 197. BRICS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. BRICS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 199. BRICS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 200. BRICS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 201. G7 NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. G7 NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 203. G7 NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 204. G7 NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 205. G7 NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 206. G7 NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 207. G7 NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 208. G7 NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 209. G7 NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 210. NATO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. NATO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 212. NATO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 213. NATO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 214. NATO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 215. NATO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 216. NATO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 217. NATO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 218. NATO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 229. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 230. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 231. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, 2018-2032 (USD MILLION)
TABLE 232. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROMES, 2018-2032 (USD MILLION)
TABLE 233. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME ANEUPLOIDIES (SCA), 2018-2032 (USD MILLION)
TABLE 234. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 235. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY GESTATION PERIOD, 2018-2032 (USD MILLION)
TABLE 236. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
TABLE 237. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Non-invasive Prenatal Testing market report include:
  • Agilent Technologies, Inc.
  • BGI Group
  • BillionToOne, Inc.
  • Biora Therapeutics, Inc.
  • BioReference Laboratories, Inc.
  • Centogene N.V.
  • Eurofins Scientific SE
  • F.Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • Igenomix S.L.U by Vitrolife Group
  • Illumina, Inc.
  • Labcorp Holdings Inc.
  • Laboratory Corporation of America Holdings
  • Lilac Insights Pvt. Ltd.
  • MedGenome Labs Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Quest Diagnostics Incorporated
  • Ravgen Inc.
  • Sonic Healthcare USA
  • Thermo Fisher Scientific Inc.
  • Yourgene Health by Novacyt UK Holdings Limited

Table Information

Report AttributeDetails
No. of Pages181
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.36 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.95 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report - Product Image

Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report

  • Report
  • 456 Pages
  • Global
From
Non-invasive Prenatal Test (NIPT) Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Non-invasive Prenatal Test (NIPT) Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 89 Pages
  • Global
From
Non-invasive Prenatal Genetic Testing Market - Global Forecast 2025-2030 - Product Image

Non-invasive Prenatal Genetic Testing Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Non-invasive Prenatal Testing Market Report 2025 - Product Image

Non-invasive Prenatal Testing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Non-Invasive Prenatal DNA Testing Service Market - Global Forecast 2025-2030 - Product Image

Non-Invasive Prenatal DNA Testing Service Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.